Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Harrow | HROW | Nov 22, 2024 | 42.90 | -2.23 |
Hartford Financial Services G Pref | HIG-G | Nov 22, 2024 | 25.13 | +0.45 |
Hartford Financial Services Group | HIG | Nov 22, 2024 | 120.72 | +0.90 |
Hartford Multifactor Developed Markets (ex-US) ETF | RODM | Nov 22, 2024 | 29.52 | +0.26 |
Harvard Bioscience | HBIO | Nov 22, 2024 | 2.27 | +5.09 |
Hasbro | HAS | Nov 22, 2024 | 62.52 | +0.99 |
Haverty Furniture Companies | HVT-A | Nov 22, 2024 | 22.27 | 0.00 |
Haverty Furniture Companies | HVT | Nov 22, 2024 | 23.55 | +1.82 |
Hawaiian Electric Industries | HE | Nov 22, 2024 | 10.61 | +1.05 |
Hawkins | HWKN | Nov 22, 2024 | 130.03 | +1.56 |
Hawthorn Bancshares | HWBK | Nov 22, 2024 | 30.42 | -1.52 |
Haymaker Acquisition 4 | HYAC | Nov 22, 2024 | 10.72 | +0.09 |
Haynes International | HAYN | Nov 22, 2024 | 60.99 | 0.00 |
Hayward | HAYW | Nov 22, 2024 | 16.06 | +0.44 |
HBT Financial | HBT | Nov 22, 2024 | 24.30 | +1.76 |
HCA Healthcare | HCA | Nov 22, 2024 | 324.93 | -2.20 |
HCI Group | HCI | Nov 22, 2024 | 111.37 | +1.01 |
HCM II Acquisition | HOND | Nov 22, 2024 | 10.00 | 0.00 |
HCM II Acquisition | HONDU | Nov 22, 2024 | 10.17 | 0.00 |
HCW Biologics | HCWB | Nov 22, 2024 | 0.77 | +8.51 |
HDFC Bank ADR | HDB | Nov 22, 2024 | 64.50 | +1.45 |
Health Catalyst | HCAT | Nov 22, 2024 | 8.13 | +6.14 |
Healthcare AI Acquisition A | HAIA | Nov 22, 2024 | 11.50 | -0.43 |
Healthcare Alphadex First Trust | FXH | Nov 22, 2024 | 109.44 | +0.56 |
Healthcare Bull 3X Direxion | CURE | Nov 22, 2024 | 106.52 | +0.13 |
Healthcare ETF Vanguard | VHT | Nov 22, 2024 | 265.83 | +0.17 |
Healthcare Realty Trust | HR | Nov 22, 2024 | 17.30 | -2.81 |
Healthcare Select Sector SPDR | XLV | Nov 22, 2024 | 144.16 | +0.09 |
Healthcare Services Group | HCSG | Nov 22, 2024 | 11.68 | +1.39 |
Healthcare Triangle | HCTI | Nov 22, 2024 | 1.09 | +1.87 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.